Network Bio's biomedical data for AI-enabled precision medicine
Network Bio has raised $17.0M in total funding. The most recent round was Seed. The last funding was announced in February 2025.
Network Bio's investors include Founders Fund, S32, Artis Ventures, Breyer Capital, Fundomo.
Network Bio is headquartered in New York, United States.
Network Bio's biomedical data for AI-enabled precision medicine
Network Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Network Bio — Funding & Investors." VCBacked, February 27, 2025, https://www.vcbacked.co/company/network-bio. Accessed August 13, 2026.
VCBacked. (2025). Network Bio — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/network-bio
{{cite web |title=Network Bio — Funding & Investors |url=https://www.vcbacked.co/company/network-bio |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated